𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Induction (neoadjuvant) chemotherapy and breast conserving treatment for locally advanced carcinoma of the breast

✍ Scribed by Christine A. Birchansky; Gordon F. Schwartz; Lydia T. Komarnicky; Ronald I. Cantor; William A. Biermann; Frederick M. Fellin; Jennifer L. Adams; Carl M. Mansfield

Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
120 KB
Volume
24
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Residual tumor uptake of [99mTc]-sestami
Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival
✍ Lisa K. Dunnwald; Julie R. Gralow; Georgiana K. Ellis; Robert B. Livingston; Han πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 209 KB

## Abstract ## BACKGROUND Studies utilizing serial [^99m^Tc]‐sestamibi (MIBI) scintimammography have reported accurate prediction of tumor response in patients with locally advanced breast carcinoma (LABC) undergoing neoadjuvant chemotherapy. The pathologic response of LABC to presurgical treatmen

Monitoring the response of patients with
Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography
✍ David A. Mankoff; Lisa K. Dunnwald; Julie R. Gralow; Georgiana K. Ellis; Mariann πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 221 KB πŸ‘ 2 views

## BACKGROUND. Mammographic and physical examination assessments of the response of locally advanced breast carcinoma (LABC) to neoadjuvant therapy have been shown to be inaccurate. The authors studied the feasibility and accuracy of [technetium 99m]-sestamibi (MIBI) for monitoring the response of